Enterprise Value
55.01M
Cash
145.8M
Avg Qtr Burn
-30.65M
Short % of Float
5.08%
Insider Ownership
2.43%
Institutional Own.
53.37%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GRANITE Details Solid tumor/s, Colorectal cancer , Gastric cancer, Cancer, Non-small cell lung carcinoma Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 2/3 Data readout | |
SLATE Details Solid tumor/s, Colorectal cancer , Lung cancer, Cancer | Phase 2 Initiation | |
samRNA Details Infectious disease, COVID-19 | Phase 1 Data readout |